Crow-Fukase syndrome associated with extramedullary plasmacytoma. 1991

S Shirabe, and M Kishikawa, and M Mine, and T Miyazaki, and H Kuratsune, and K Tobinaga
Department of Internal Medicine, Isahaya Health Insurance General Hospital, Japan.

A patient with extramedullary solitary tumor had progressive sensory motor neuropathy, generalized pigmentation of skin, pretibial edema and gynecomastia. Serological examination of this patient showed monoclonal IgA-lambda gammopathy. Histologically, the tumor was defined as an IgA (lambda type) positive extramedullary plasmacytoma by using peroxidase anti-peroxidase staining. The tumor was accompanied by angiofollicular lymphoid hyperplasia. Pathologically, it was recognized as an extramedullary plasmacytoma associated with Castleman's disease like changes, and was successfully treated by surgical resection, followed by irradiation.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007146 Immunoglobulin lambda-Chains One of the types of light chain subunits of the immunoglobulins with a molecular weight of approximately 22 kDa. Ig lambda Chains,Immunoglobulins, lambda-Chain,Immunoglobulin lambda-Chain,lambda-1-Immunoglobulin,lambda-2-Immunoglobulin,lambda-Chain Immunoglobulins,lambda-Immunoglobulin Light Chain,lambda-Immunoglobulin Light Chains,lambda-x Immunoglobulin,Chains, Ig lambda,Chains, lambda-Immunoglobulin Light,Immunoglobulin lambda Chain,Immunoglobulin lambda Chains,Immunoglobulin, lambda-x,Immunoglobulins, lambda Chain,Light Chain, lambda-Immunoglobulin,Light Chains, lambda-Immunoglobulin,lambda 1 Immunoglobulin,lambda 2 Immunoglobulin,lambda Chain Immunoglobulins,lambda Chains, Ig,lambda Immunoglobulin Light Chain,lambda Immunoglobulin Light Chains,lambda x Immunoglobulin,lambda-Chain, Immunoglobulin,lambda-Chains, Immunoglobulin
D008297 Male Males
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D010257 Paraneoplastic Syndromes In patients with neoplastic diseases a wide variety of clinical pictures which are indirect and usually remote effects produced by tumor cell metabolites or other products. Paraneoplastic Syndrome,Syndrome, Paraneoplastic,Syndromes, Paraneoplastic
D010523 Peripheral Nervous System Diseases Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves. Peripheral Nerve Diseases,Peripheral Neuropathies,PNS (Peripheral Nervous System) Diseases,PNS Diseases,Peripheral Nervous System Disease,Peripheral Nervous System Disorders,Nerve Disease, Peripheral,Nerve Diseases, Peripheral,Neuropathy, Peripheral,PNS Disease,Peripheral Nerve Disease,Peripheral Neuropathy
D010954 Plasmacytoma Any discrete, presumably solitary, mass of neoplastic PLASMA CELLS either in BONE MARROW or various extramedullary sites. Plasma Cell Tumor,Plasmocytoma,Plasma Cell Tumors,Plasmacytomas,Plasmocytomas,Tumor, Plasma Cell,Tumors, Plasma Cell
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004487 Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. Dropsy,Hydrops,Anasarca
D006177 Gynecomastia Enlargement of the BREAST in the males, caused by an excess of ESTROGENS. Physiological gynecomastia is normally observed in NEWBORNS; ADOLESCENT; and AGING males. Adolescent Gynecomastia,Infant Gynecomastia,Male Breast Enlargement,Newborn Gynecomastia,Breast Enlargement, Male,Enlargement, Male Breast,Gynecomastia, Adolescent,Gynecomastia, Infant,Gynecomastia, Newborn

Related Publications

S Shirabe, and M Kishikawa, and M Mine, and T Miyazaki, and H Kuratsune, and K Tobinaga
February 1987, Rinsho shinkeigaku = Clinical neurology,
S Shirabe, and M Kishikawa, and M Mine, and T Miyazaki, and H Kuratsune, and K Tobinaga
January 2001, Rinsho shinkeigaku = Clinical neurology,
S Shirabe, and M Kishikawa, and M Mine, and T Miyazaki, and H Kuratsune, and K Tobinaga
April 2003, Rinsho shinkeigaku = Clinical neurology,
S Shirabe, and M Kishikawa, and M Mine, and T Miyazaki, and H Kuratsune, and K Tobinaga
July 1993, Internal medicine (Tokyo, Japan),
S Shirabe, and M Kishikawa, and M Mine, and T Miyazaki, and H Kuratsune, and K Tobinaga
March 1995, Nihon rinsho. Japanese journal of clinical medicine,
S Shirabe, and M Kishikawa, and M Mine, and T Miyazaki, and H Kuratsune, and K Tobinaga
September 1985, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
S Shirabe, and M Kishikawa, and M Mine, and T Miyazaki, and H Kuratsune, and K Tobinaga
January 1999, Ryoikibetsu shokogun shirizu,
S Shirabe, and M Kishikawa, and M Mine, and T Miyazaki, and H Kuratsune, and K Tobinaga
December 1989, Rinsho shinkeigaku = Clinical neurology,
S Shirabe, and M Kishikawa, and M Mine, and T Miyazaki, and H Kuratsune, and K Tobinaga
September 2000, Neuropathology : official journal of the Japanese Society of Neuropathology,
S Shirabe, and M Kishikawa, and M Mine, and T Miyazaki, and H Kuratsune, and K Tobinaga
January 1986, Virchows Archiv. A, Pathological anatomy and histopathology,
Copied contents to your clipboard!